Close Menu

NEW YORK (360Dx) – Bio-Rad Laboratories said today that the US Food and Drug Administration has cleared for marketing its BioPlex 2200 Syphilis Total & RPR (rapid plasma reagin) assay, a one-step universal testing method to aid in the diagnosis of syphilis infection.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.